1,839
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Patterns of prescription and discontinuation of contraceptives for Swedish women with obesity and normal-weight women

, ORCID Icon, , & ORCID Icon
Pages 192-197 | Received 20 Feb 2019, Accepted 20 Apr 2019, Published online: 21 May 2019

References

  • Collaboration NCDRF. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387:1377–1396.
  • World Health Organization. Obesity and overweight. Fact sheet. 2018 [cited 2019 April 7] https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight.
  • Folkhälsomyndigheten. Så mår Sveriges befolkning. 2018 [cited 2019 April 7]. https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2018/december/sa-mar-sveriges-befolkning–ny-statistik-om-folkhalsan-2018/.
  • Lindh I, Skjeldestad FE, Gemzell-Danielsson K, et al. Contraceptive use in the Nordic countries. Acta Obstet Gynecol Scand. 2017;96:19–28.
  • Odlind VB, Milson I, Familjeplanering:preventivmetoder, aborter och rådgivning. 1st ed. Lund: Studentlitteratur AB; 2008.
  • Josefsson A, Wirehn AB, Lindberg M, et al. Continuation rates of oral hormonal contraceptives in a cohort of first-time users: a population-based registry study, Sweden 2005-2010. BMJ Open. 2013;3:e003401.
  • Hall KS, Trussell J, Schwarz EB. Progestin-only contraceptive pill use among women in the United States. Contraception. 2012;86:653–658.
  • Goldhaber SZ, Grodstein F, Stampfer MJ, et al. A prospective study of risk factors for pulmonary embolism in women. JAMA. 1997;277:642–645.
  • Pomp ER, le Cessie S, Rosendaal FR, et al. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol. 2007;139:289–296.
  • Parkin L, Sweetland S, Balkwill A, et al. Body mass index, surgery, and risk of venous thromboembolism in middle-aged women: a cohort study. Circulation. 2012;125:1897–1904.
  • Merki-Feld GS, Skouby S, Serfaty D, et al. European society of contraception statement on contraception in obese women. Eur J Contracept Reprod Health Care. 2015;20:19–28.
  • Läkemedelsverket. Antikonception-behandlingsrekommendation. Information Från Läkemedelsverket. 2014;25:14–28. Swedish.
  • Westhoff CL, Torgal AH, Mayeda ER, et al. Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women. Contraception. 2010;81:474–480.
  • Westhoff CL, Torgal AH, Mayeda ER, et al. Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial. Obstet Gynecol. 2010;116:275–283.
  • Edelman AB, Cherala G, Munar MY, et al. Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users. Contraception. 2013;87:220–226.
  • McNicholas C, Zhao Q, Secura G, et al. Contraceptive failures in overweight and obese combined hormonal contraceptive users. Obstet Gynecol. 2013;121:585–592.
  • Lopez LM, Bernholc A, Chen M, et al. Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database Syst Rev. 2016;18:CD008452.
  • Edelman AB, Carlson NE, Cherala G, et al. Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity. Contraception. 2009;80:119–127.
  • Westhoff CL, Torgal AH, Mayeda ER, et al. Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women. Am J Obstet Gynecol. 2012;207:39 e1–36.
  • Kopp Kallner H, Thunell L, Brynhildsen J, et al. Use of contraception and attitudes towards contraceptive use in Swedish women – a nationwide survey. PLoS One. 2015;10:e0125990.
  • Zigler RE, McNicholas C. Unscheduled vaginal bleeding with progestin-only contraceptive use. Am J Obstet Gynecol. 2017;216:443–450.
  • Belsey EM. Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception. Contraception. 1988;38:181–206.
  • Broome M, Fotherby K. Clinical experience with the progestogen-only pill. Contraception. 1990;42:489–495.
  • Ginstman C, Frisk J, Ottosson J, et al. contraceptive use before and after gastric bypass: a questionnaire study. Obes Surg. 2015;25:2066–2070.
  • Läkemedelsverket. Antikonception – Behandlingsrekommendation. Information från läkemedelsverket. 2005;16(7):7–84. Swedish.
  • Dianat S, Fox E, Ahrens KA, et al. Side effects and health benefits of depot medroxyprogesterone acetate: a systematic review. Obstet Gynecol. 2019;133:332–341.
  • Lindh I, Hognert H, Milsom I. The changing pattern of contraceptive use and pregnancies in four generations of young women. Acta Obstet Gynecol Scand. 2016;95:1264–1272.
  • Trussell J. Contraceptive failure in the United States. Contraception. 2011;83:397–404.
  • Winkler UH. Hemostatic effects of third- and second-generation oral contraceptives: absence of a causal mechanism for a difference in risk of venous thromboembolism. Contraception. 2000;62:11S–20S. discussion 37S-38S.
  • Rabe TL, Ludwig M, Dinger JC, et al. Contraception and thrombophilia – a statement from the German Society of Gynecological Endocrinology and Reproductive Medicine (DGGEF e. V.) and the Professional Association of the German Gynaecologists (BVF e. V.). J Reprod Endokrinol. 2011;8:178–218.
  • McKeating A, O’Higgins A, Turner C, et al. The relationship between unplanned pregnancy and maternal body mass index 2009-2012. Eur J Contracept Reprod Health Care. 2015;20:409–418.